US equities |
SPCX $168.34 ▲+5.90% NVDA $237.26 ▲+1.41% MU $1,066.88 ▼-0.75% TSLA $379.41 ▲+2.38% MSFT $526.04 ▲+1.64% SNDK $1,716.05 ▼-0.23% INTC $117.12 ▼-1.85% META $743.63 ▲+2.14%
FinancialContent

Articles published by Turn Therapeutics, Inc.

News headline image
Turn Therapeutics Appoints Former CDC Director Robert R. Redfield, M.D., as Chief Scientific Officer
From Turn Therapeutics, Inc.
Via Business Wire
Tickers TTRX
News headline image
Turn Therapeutics Announces Final Stage 2 Design and Data-Driven Expansion of GX-03 Phase 2 Program in Atopic Dermatitis
From Turn Therapeutics, Inc.
Via Business Wire
Tickers TTRX
News headline image
Turn Therapeutics to Host Webcast Presenting Comprehensive Interim Analysis and Optimized Stage 2 Design for GX-03 in Atopic Dermatitis
From Turn Therapeutics, Inc.
Via Business Wire
Tickers TTRX
News headline image
Turn Therapeutics Secures Up to $25 Million in Financing From Avenue Capital Group
From Turn Therapeutics, Inc.
Via Business Wire
Tickers TTRX
News headline image
Turn Therapeutics Appoints Dr. Robert Redfield as Senior Advisor of Health Policy and Regulatory Affairs
From Turn Therapeutics, Inc.
Via Business Wire
Tickers TTRX
News headline image
Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44th Annual J.P. Morgan Healthcare Conference
From Turn Therapeutics, Inc.
Via Business Wire
Tickers TTRX